Advertisement

Topics

New Indication For BRIVIACT (Brivaracetam): s Newest Antiepileptic Drug Approved By FDA As Monotherapy Treatment Of Partial-Onset Seizures In Adults

20:00 EDT 14 Sep 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: New Indication For BRIVIACT (Brivaracetam): s Newest Antiepileptic Drug Approved By FDA As Monotherapy Treatment Of Partial-Onset Seizures In Adults

NEXT ARTICLE

More From BioPortfolio on "New Indication For BRIVIACT (Brivaracetam): s Newest Antiepileptic Drug Approved By FDA As Monotherapy Treatment Of Partial-Onset Seizures In Adults"

Quick Search
Advertisement